Edgewise Therapeutics, Inc., a biopharmaceutical company that researches treatments for diseases like muscular dystrophy, has hired John Moore as its first general counsel from Peloton Therapeutics Inc.
“I’m excited to join Edgewise at this point in the company’s evolution as we build on the ongoing accomplishments of our innovative research engine to move product candidates into the clinic,” Moore said in an Oct. 29 statement. He officially assumed his new position in September.
Edgewise has hired several executives since June, including Behrad Derakhshan as chief business officer, Michael Carruthers as chief financial officer, Abby Bronson as vice president of patient ...